Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction

Renicus S Hermanides1, Jan-Paul Ottervanger, Jan-Henk E Dambrink

  • 1Isala klinieken, Location Weezenlanden, Department of Cardiology, Zwolle, The Netherlands.

Insights

Major bleeding after primary percutaneous coronary intervention for ST elevation myocardial infarction is infrequent but significantly increases mortality risk. Identifying predictors like Killip class is crucial for patient outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Research

Background:

  • ST elevation myocardial infarction (STEMI) is a critical condition requiring prompt reperfusion.
  • Primary percutaneous coronary intervention (PCI) is the standard treatment for STEMI.
  • Bleeding complications post-PCI can impact patient prognosis.

Purpose of the Study:

  • To determine the incidence of bleeding in STEMI patients undergoing primary PCI.
  • To identify predictors of both major and minor bleeding.
  • To evaluate the prognostic impact of bleeding on one-year mortality.

Main Methods:

  • Prospective, observational study of 5,030 consecutive STEMI patients (1991-2004).
  • Data collected on bleeding events within 48 hours of primary PCI.
  • Cox proportional hazard models used to assess the association between bleeding and mortality.

Main Results:

  • Major bleeding occurred in 1.6% (n=80) and minor bleeding in 5.6% (n=266) of 4,717 evaluable patients.
  • Predictors of minor bleeding included advanced age, multivessel disease, Killip class ≥2, anterior MI, and TIMI 0 flow pre-PCI.
  • Killip class ≥2 was an independent predictor of major bleeding.

Conclusions:

  • Major bleeding incidence post-primary PCI for STEMI is low (<2%).
  • Major bleeding is a strong, independent predictor of increased one-year mortality.
  • Risk stratification considering bleeding predictors may improve STEMI patient management.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...